APA (7th ed.) Citation

Nagu, T., Aboud, S., Rao, M., Matee, M., Axelsson, R., Valentini, D., . . . Maeurer, M. (2017). Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy. International journal of infectious diseases, 56(C), 136-139. https://doi.org/10.1016/j.ijid.2017.01.022

Chicago Style (17th ed.) Citation

Nagu, Tumaini, Said Aboud, Martin Rao, Mecky Matee, Rebecca Axelsson, Davide Valentini, Ferdinand Mugusi, Alimuddin Zumla, and Markus Maeurer. "Strong Anti-Epstein Barr Virus (EBV) or Cytomegalovirus (CMV) Cellular Immune Responses Predict Survival and a Favourable Response to Anti-tuberculosis Therapy." International Journal of Infectious Diseases 56, no. C (2017): 136-139. https://doi.org/10.1016/j.ijid.2017.01.022.

MLA (9th ed.) Citation

Nagu, Tumaini, et al. "Strong Anti-Epstein Barr Virus (EBV) or Cytomegalovirus (CMV) Cellular Immune Responses Predict Survival and a Favourable Response to Anti-tuberculosis Therapy." International Journal of Infectious Diseases, vol. 56, no. C, 2017, pp. 136-139, https://doi.org/10.1016/j.ijid.2017.01.022.